Back

Advanced heart failure in patients with dilated cardiomyopathy and high-risk arrhythmic genotypes

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Myocarditis and dilated cardiomyopathy Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nerea Mora Ayestaran

Navarra University Hospital, Pamplona, Navarra (Spain)

6 More presentations in this session

Presentation thumbnail
Discussant - Myocarditis and dilated cardiomyopathy
Presentation thumbnail
Long term cardiac function and symptoms in patients following COVID-19 vaccination myocarditis
Mr M. Ramadan (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
National cohort of suspected myocarditis PreMYO: clinical management of the first 575 cases.
Doctor F. Dominguez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Early detection of regional wall motion abnormalities in Chagas disease using fast strain-encoded cardiac magnetic resonance (Fast-SENC) in a non-endemic zone
Doctor G. De la Osa Hernandez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Integrating electrocardiographic and echocardiographic findings in predicting desmoplakin gene variants in dilated and nondilated left ventricular cardiomyopathy
Doctor A. Apostu (Bucharest, RO)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Myocarditis and dilated cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Arrhythmic genotypes and risk of major ventricular arrhythmia in dilated cardiomyopathy: a multicentre japanese cohort
thumbnail
Congress Session
Guidelines in Practice: risk stratification for sudden cardiac death in dilated cardiomyopathy - time to move beyond ejection fraction?
thumbnail
Congress Presentation
'The overlooked middle': patient with non-ischaemic cardiomyopathy and moderately impaired ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources